A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab. Read more about A test-based strategy is more cost effective than empiric dose escalation for patients with Crohn's disease who lose responsiveness to infliximab.
Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma. Read more about Factors associated with outcomes and response to therapy in patients with infiltrative hepatocellular carcinoma.
Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children. Read more about Validation and modification of simplified diagnostic criteria for autoimmune hepatitis in children.
Multidisciplinary management of hepatocellular carcinoma. Read more about Multidisciplinary management of hepatocellular carcinoma.
Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy. Read more about Design and validation of the biliary atresia research consortium histologic assessment system for cholestasis in infancy.
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Read more about New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt.
Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Read more about Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis.
Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma. Read more about Utility of Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein and des-gamma-carboxy prothrombin, alone or in combination, as biomarkers for hepatocellular carcinoma.
Management of obscure occult gastrointestinal bleeding: a cost-minimization analysis. Read more about Management of obscure occult gastrointestinal bleeding: a cost-minimization analysis.
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Read more about Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium.